Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1243940

registered interest
date	15/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on patient survival rates of delayed diagnosis and screening for colorectal cancer as a result of the covid-19 outbreak.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	104093
answer	answer is ministerial correction date of answer 04/11/2020 answer text <p>The UK National Screening Committee is undertaking work to estimate the impact of delays to screening programmes, including cancer screening, caused by the COVID-19 pandemic. This work is currently in its early stages and the results will be reported as soon they are available.</p><p>NHS England and NHS Improvement is working to clear the backlog of bowel cancer screening as quickly as possible. All 64 bowel screening centres are now undertaking diagnostic colonoscopies and sending routine screening invitations. As at 5 October 2020, the number of people who have had a faecal immunochemical test-positive result and are awaiting a diagnostic test has nearly halved in comparison to those waiting in April 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/11/2020 11:20:41 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1243942

registered interest
date	15/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the care and treatment provided to people with metastatic colorectal cancer in England in light of survival rates being lower than comparable European countries.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	104094
answer	answer is ministerial correction date of answer 27/11/2020 answer text <p>There is a wide range of treatment options available to manage metastatic colorectal cancer and these are set out within pathway guidance published by the National Institute for Health and Care Excellence.</p><p>While treatment decisions are based on individual clinical circumstances, systemic anti-cancer treatment is the mainstay of care. There are a number of treatments available depending on where the colorectal cancer has spread. For example, where cancer is in the liver, patients may be able to access interventional procedures including laparoscopic resection and ablative treatments as well as radiotherapy (Selective Internal Radiation Therapy and Stereotactic Ablative Radiotherapy).</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/11/2020 12:10:22 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith